Thyroid remnant ablation with radioiodine activity of 30, 60, and 100 mCi in patients with differentiated thyroid cancer – a prospective comparison of long-term outcomes

por Kukulska, Aleksandra, Krajewska, Jolanta, Gawkowska, Marzena, Paliczka-Cieslik, Ewa, Handkiewicz-Junak, Daria, Kropińska, Aleksandra, Puch, Zbigniew, Olczyk, Tomasz, Roskosz, Jozef, Jarzab, Barbara
Publicado 2020

Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi

por Kukulska, Aleksandra, Krajewska, Jolanta, Gawkowska-Suwińska, Marzena, Puch, Zbigniew, Paliczka-Cieslik, Ewa, Roskosz, Jozef, Handkiewicz-Junak, Daria, Jarzab, Michał, Gubała, Elzbieta, Jarzab, Barbara
Publicado 2010

13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patie...

por Handkiewicz-Junak, Daria, Roskosz, Jozef, Hasse-Lazar, Kornelia, Szpak-Ulczok, Sylwia, Puch, Zbigniew, Kukulska, Aleksandra, Olczyk, Tomasz, Piela, Andrzej, Paliczka-Cieslik, Ewa, Jarzab, Barbara
Publicado 2009

Postoperative Radioiodine Treatment within 9 Months from Diagnosis Significantly Reduces the Risk of Relapse in Low-Risk Differentiated Thyroid Carcinoma

por Krajewska, Jolanta, Jarzab, Michal, Kukulska, Aleksandra, Czarniecka, Agnieszka, Roskosz, Jozef, Puch, Zbigniew, Wygoda, Zbigniew, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Krol, Aleksandra, Handkiewicz-Junak, Daria, Jarzab, Barbara
Publicado 2019

The role of postoperative adjuvant radiotherapy in local recurrence risk in medullary thyroid carcinoma

por Kukulska, Aleksandra, Krajewska, Jolanta, Kolosza, Zofia, Paliczka-Cieslik, Ewa, Kropinska, Aleksandra, Pawlaczek, Agnieszka, Puch, Zbigniew, Ficek, Kornelia, Lisik, Teresa, Sygula, Dorota, Wygoda, Zbigniew, Roskosz, Jozef, Wydmanski, Jerzy, Jarzab, Barbara
Publicado 2019